Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline-Reference-Cited by-同舟云学术

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Published:2012-04-02 Issue:4 Volume:122 Page:1316-1338
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Talbot Konrad,Wang Hoau-Yan,Kazi Hala,Han Li-Ying,Bakshi Kalindi P.,Stucky Andres,Fuino Robert L.,Kawaguchi Krista R.,Samoyedny Andrew J.,Wilson Robert S.,Arvanitakis Zoe,Schneider Julie A.,Wolf Bryan A.,Bennett David A.,Trojanowski John Q.,Arnold Steven E.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference173 articles.

1. Insulin resistance as the core defect in type 2 diabetes mellitus

2. Pathogenesis of type 2 diabetes mellitus

3. Common pathological processes in Alzheimer disease and type 2 diabetes: A review

4. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease

5. Risk of dementia in diabetes mellitus: a systematic review

Cited by 1455 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin-resistance as a modifiable pathway to cognitive dysfunction in schizophrenia: A systematic review;Schizophrenia Research;2024-12

2. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges;Life Sciences;2024-10

3. Protein tyrosine phosphatase receptor type O serves as a key regulator of insulin resistance-induced α-synuclein aggregation in Parkinson’s disease;Cellular and Molecular Life Sciences;2024-09-14

4. Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies;Molecular Neurobiology;2024-09-06

5. Methylglyoxal induces death in human brain neuronal cells (SH-SY5Y), prevented by metformin and dapagliflozin;Journal of Diabetes and its Complications;2024-09